PKM and esophageal squamous cell carcinoma: Given that aerobic glycolysis is a key for most tumor cells to maintain rapid growth and metastasis and PKM2 is the key metabolic enzyme for glycolysis, whether Shikonin inhibits ESCC cell growth via blocking the aerobic glycolysis was tested.